Legal

The Most Hated Man in America Martin Shkreli May Face New Charges

The Most Hated Man in America Martin Shkreli May Face New Charges
Image credit: Eduardo Munoz Alvarez / Stringer | Getty Images
Entrepreneur Staff
1 min read

Remember Martin Shkreli, the charming former CEO of Turing Pharmaceuticals, who jacked up the price of AIDS and cancer drug Daraprim from $13.50 to $750 a pill? When he appeared in U.S. District Court in Brooklyn today on existing fraud charges, it was revealed that he may face an additional indictment as well. (How the crowd didn't erupt into applause we don't quite understand.)

The details of the new indictment were not made public, but given that he was arrested last December on multiple charges of securities and wire fraud, we'll guess that they are nothing to be proud of.

RELATED: 5 PR Tips for Martin Shkreli AKA the 'Most-Hated Man' in America

Speaking to reporters, Shkreli's attorney Ben Brafman said in part, "I think today was a good day for Martin Shkreli." Really? It's "a good day" when you get new charges piled on your old charges? Oh Marty, we're glad this guy is your lawyer.
 
 

More from Entrepreneur

Jason's expertise and experience can help you with storytelling, motivation, and pitching your business to media.
Book Your Session

For a limited time only, get this bundle of Entrepreneur PressĀ® titles for less than $30 (60% OFF) on our bookstore when you use "LEAP" at checkout.
Buy Now

Are paying too much for business insurance? Do you have critical gaps in your coverage? Trust Entrepreneur to help you find out.
Get Your Quote Now

Latest on Entrepreneur

My Queue

There are no Videos in your queue.

Click on the Add to next to any video to save to your queue.

There are no Articles in your queue.

Click on the Add to next to any article to save to your queue.

There are no Podcasts in your queue.

Click on the Add to next to any podcast episode to save to your queue.

You're not following any authors.

Click the Follow button on any author page to keep up with the latest content from your favorite authors.